News AI returns voice to paralysed woman after 18 years A stroke survivor has been given back the ability to speak for the first time in 18 years, after a breakthrough
News Biogen trumpets data from ALS trial as FDA decision looms After a torrid couple of years, Biogen can be forgiven for making the most of new data on its tofersen drug for amyotrophic lateral sclerosis (ALS) – with an elevated status among its pipel
News AI-discovered candidates show promise in ALS Candidates slow down motor neurone death in patient samples.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
